| TMP-SMX | trimethoprim-sulfamethaxole; trimethoprim-sulfamethoxazole |
|---|---|
| DS | dead air space; dead space; deep sedative; deep sleep; defined substrate; dehydroepiandrosterone sul... |
| AS | acetylstrophanthidin; acidified serum; acoustic schwannoma; acoustic stimulation; active sarcoidosis... |
| BPN | bacitracin, polymyxin B, neomycin sulfate; brachial plexus neuropathy |
| PBN | paralytic brachial neuritis; peripheral benign neoplasm; polymyxin B sulfate, bacitracin, and neomyc... |
| PB | Polymyxin B |
|---|---|
| PMX-B | Polymyxin B |
| PXB | Polymyxin B |
| PMBN | Polymyxin B nonapeptide |
| trimethoprim | 2,4-diamino)-5-(3,4,5-trimethoxy-benzyl)-pyrimidine |
| polymyxin B sulfate | An antibacterial effective in tularaemia, brucellosis, Pseudomonas infections, and urinary tract infections, but used systemically only for severe infections not responsive to less toxic agents; it is also used locally. Polymyxin B is a mixture of polymyxin B1 and polymyxin B2. (05 Mar 2000) |
|---|---|
| polymyxin | <chemical> Basic polypeptide antibiotic group obtained from bacillus polymyxa. They affect the cell membrane by detergent action and may cause neuromuscular and kidney damage. at least eleven different members of the polymyxin group have been identified, each designated by a letter. Pharmacological action: antibiotics, peptide. (12 Dec 1998) |
| polymyxin acylase | <enzyme> Deacylates polymyxin, colistin and octapeptin antibiotic Registry number: EC 3.5.1.- (26 Jun 1999) |
| polymyxin b | <chemical> A mixture of polymyxins b1 and b2, obtained from bacillus polymyxa strains. They are basic polypeptides of about eight amino acids and have cationic detergent action on cell membranes. Polymyxin b is used for infections with gram-negative organisms, but may be neurotoxic and nephrotoxic. Pharmacological action: antibiotics, peptide. Chemical name: Polymyxin B (12 Dec 1998) |
| trimethoprim | <drug> A drug that inhibits the reduction of dihydrofolate to tetrahydrofolate (a later step than that inhibited by sulphonamides). Selective for some bacterial dihydrofolate reductases and often used in conjunction with sulphonamides. (19 Jan 1998) |
| trimethoprim resistance | Nonsusceptibility of a bacterium to the action of trimethoprim. (12 Dec 1998) |
| trimethoprim-sulfamethoxazole | A drug combination consisting of a dihydrofolate reductase inhibitor (trimethoprim) and a sulfonamide antibacterial drug (sulfamethoxazole). The drug combination is synergistic as the drugs interfere with two successive steps in the formation/utilization of folic acid by microorganisms. Used to treat many infectious diseases. (05 Mar 2000) |
| trimethoprim-sulfamethoxazole combination | <chemical> 4-amino-n-(5-methyl-3-isoxazolyl)benzenesulfonamide mixture with 5-((3,4,5-trimethoxyphenyl)methyl)- 2,4-pyrimidinediamine. This drug combination has proved to be an effective therapeutic agent with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including pneumocystis carinii pneumonia in aids, but is the drug of choice for urinary infection. Pharmacological action: anti-infective agents, anti-infective agents, urinary, antimalarials. Chemical name: Benzenesulfonamide, 4-amino-N-(5-methyl-3-isoxazolyl)-, mixt. With 5-((3,4,5-trimethoxyphenyl)methyl)-2,4-pyrimidinediamine (12 Dec 1998) |
| acetic solution | A vinegar. (05 Mar 2000) |
| amaranth solution | A 1% solution of amaranth (trisodium naphthol sulfonic acid), a synthetic vivid red dye, stable in acid and intensified in sodium hydroxide solution; used as a red or pink colourant in liquid pharmaceuticals. (05 Mar 2000) |
| aqueous solution | <chemistry> A solution in which water is the dissolving medium or solvent. (09 Jan 1998) |
| barium solution | A liquid containing barium sulfate, which shows up on X-rays. It outlines organs of the body so they can be seen on X-ray film. (12 Dec 1998) |
| Benedict's solution | <chemistry> An aqueous solution of sodium citrate, sodium carbonate, and copper sulfate which changes from its normal blue colour to orange, red, or yellow in the presence of a reducing sugar such as glucose. See: Benedict's test for glucose. (14 Aug 2000) |
| Burow's solution | A preparation of aluminium subacetate and glacial acetic acid, used for its antiseptic and astringent action on the skin. (05 Mar 2000) |
| Gallego's differentiating solution | A dilute solution of formaldehyde and acetic acid used in a modified Gram stain to differentiate and enhance the basic fuchsin binding to Gram-negative microorganisms. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|